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Aim To analyze the trend of lung cancer mortality in Mon-
tenegro from 1990 to 2015.
Methods Data on lung cancer mortality were collected 
from death certificates obtained from the Statistical Office 
of Montenegro for the period 1990-2009 and the Institute 
for Public Health for the period 2010-2015. Population data 
were obtained from the Statistical Office of Montenegro. 
Rates were age-standardized to the World Standard Popu-
lation, and mortality trends were analyzed with the join-
point regression.
Results In 2015, lung cancer accounted for 5.44% of all 
deaths and 22.92% of all cancer deaths. It was the leading 
cause of all cancer deaths and the third-leading cause of 
all deaths. A joinpoint was observed in 2004 in women and 
in the entire population, and in 2005 in men. The overall 
mortality rates increased from 1990 to 2004 by an average 
of 3.91% per year and decreased from 2004 to 2015 by an 
average of 1.95%; which in the entire observed period re-
sulted in an average increase of 1.3% per year. A particular-
ly strong growth rate was observed in women, even 7.14% 
in the period from 1990 to 2004.
Conclusion The observed increase in lung cancer mortal-
ity warrants improved tobacco control.
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Lung cancer is the main cause of all cancer deaths among 
men, and it has replaced breast cancer as the main cause 
of all cancer deaths among women in more developed 
countries (1). In 2012, lung cancer caused 24% of cancer 
deaths in men and 14% in women worldwide (1,2). In the 
same year there were also approximately 1.6 million lung 
cancer-related deaths, and by 2035 this number is expect-
ed to increase by 86% (1-3). The highest risk factor for lung 
cancer is smoking, even smoking a few cigarettes per day 
(4). As many as 80% of lung cancer cases in men and 50% 
in women are caused by smoking (5,6), making tobacco 
control the key strategy for lung cancer prevention (2,7,8). 
The process of active tobacco control in Montenegro was 
initiated in 2003 by establishing the National Tobacco Con-
trol Commission and developing the National Strategy for 
Tobacco Control (9), which derives fundamental concepts 
from international documents related to tobacco control 
in Europe (10-12). It introduced measures (13-16) and law 
regulations (17,18) for improving tobacco control in Mon-
tenegro (19).
In the period 1976 to 2000 an increasing trend of lung can-
cer mortality was observed in Montenegro, with a signifi-
cant correlation between lung cancer mortality rate and 
tobacco products use (20). More recent trends have not 
been analyzed and it is not known whether the trend of 
lung cancer mortality changed after the changes in smok-
ing prevalence at the beginning of the 21st century (21-
23). The aim of this article is to analyze the trend of lung 
cancer mortality in Montenegro for the period 1990-2015 
by using joinpoint regression (24,25).
MATERIAL AND METHODS
Data sources
The study gathered data on lung cancer mortality in Mon-
tenegro from 1990 to 2015. The primary data source were 
death certificates completed by physicians who deter-
mined the time and cause of death. The certificates for 
the period until 2009 were obtained from the Statistical 
Office of Montenegro and for the period after 2009 from 
the Institute for Public Health. Lung cancer was defined 
by using the International Classification of Diseases code 
162 from the 9th edition, and codes C33 and C34 from the 
10th edition (26). The number of death cases of lung can-
cer was published in the Statistical Yearbooks of the Insti-
tute of Public Health for the period 1999-2009 (27). Pop-
ulation data were obtained from the Statistical Office of 
Montenegro.
Statistical analyses
Rates were age-standardized to the World Standard Pop-
ulation (28) for the estimation of overall and sex-related 
trends. The joinpoint regression model was used to ana-
lyze long-term trends in lung cancer mortality and detect 
the time points when there was a significant change in the 
linear time trend. In the joinpoint regression model, the de-
pendent variable x is the year and the independent vari-
able y is the logarithmically transformed mortality rate. The 
models also estimated annual percentage change and av-
erage annual percentage change of lung cancer rates. Sta-
tistical analysis was carried out with the Joinpoint software, 
version 4.6.0.0 (April 2018, available from the Surveillance 
Research Program of the US National Cancer Institute) (29). 
The selected method for analysis was Grid-search method. 
The minimum number of observations for the number of 
points from the end of the time series to the first joinpoint 
was set to 3, and the minimum number of observations 
between two joinpoints was set to 4. The number of join-
points was set between 0 and 4. The permutation test was 
used to choose the best fit joinpoint model, with the total 
significance level of 0.05. The difference between men and 
women was determined with the parallelism test (30).
RESULTS
In 2015, lung cancer ranked third among all death causes 
and accounted for 5.44% of all deaths (6.68% in men, 2.79% 
in women) and for 22.80% of all cancer deaths (30.41% in 
men, 13.23% in women). In terms of total cancer mortality, 
it ranked first among men and second among women.
The total number of deaths from lung cancer increased 
from 163 in 1990 to 297 in 2015 (133 to 222 in men, 30 to 75 
in women), which equals to an increase of 82.2% (66.9% in 
men and 150% in women). Age-standardized rates ranged 
from 19.3/100 000 in 1993 to 33.8/100 000 in 2005. In men, 
age-standardized rates increased from 40/100 000 in 1990 
to 43/100 000 in 2015, and in women from 6/100 000 to 
13/100 000. Death rate ratio between men and women in 
1990 was 5.85. Rates among women were rising faster and 
approached the rates in men. Therefore, the ratio in 2015 
was 43.10% lower than in 1990 (Table 1).
Joinpoint regression showed a joinpoint in 2004 for the en-
tire population and for women, and in 2005 for men. In the 
observed period, lung cancer mortality rates significantly 
increased in the entire population (average annual per-
centage change [AAPC] = 1.3%; 95% confidence in-
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terval [CI] 0.4-2.1; P < 0.001) and in women (AAPC = 3.5%; 
95% CI 2.1-4.9; P < 0.001) and not significantly in men 
(AAPC = 0.6%; 95% CI -0.4 to 1.6; P = 0.300) (Table 2).
The overall mortality rates increased from 1990 to 2004 
(annual percent change [APC] = 3.91%, 95% CI 2.7-5.1; 
P < 0.001) and decreased from 2004 to 2015 (APC = - 1.95%; 
95% CI - 3.3 to -0.6; P < 0.001) (Figure 1). In men, the rates 
increased to 2005 (APC = 2.88%; 95% CI 1.6-4.1; P < 0.001), 
after which they decreased by an average 2.79% per year 
(95% CI -4.7 to -0.9; P < 0.001). In women, they were increas-
ing faster than in men, with the rate of 7.14% in the peri-
od 1990-2004 (APC = 7.14%; 95% CI 5.1-9.2; P < 0.001). After 
2004, the rates in women remained unchanged (P = 0.400). 
The parallelism test showed that the mortality trend line of 
lung cancer in men and women was not parallel (P < 0.001) 
(Figure 2).
DISCUSSION
The joinpoint analysis showed that standardized rates of 
lung cancer mortality in Montenegro peaked in the early 
21st century. The rates were growing in the overall pe-
riod on average by 1.3% per year. The trend changed in 
TAbLE 1. Deaths from lung cancer in Montenegro from 1990-2015
Men Women All
Year n ASR* n ASR n ASR Rate ratio male/female
1990 133 40.3 30  6.9 163 22.2 5.8
1991 124 40.2 28  7.1 152 21.6 5.7
1992 106 32.3 25  6.3 131 19.9 5.1
1993 113 33.9 31  7.8 144 19.3 4.3
1994 151 43.0 23  5.5 174 22.4 7.8
1995 153 43.1 33  7.1 186 23.4 6.1
1996 134 36.7 35  7.8 169 20.9 4.7
1997 156 41.1 37  8.3 193 23.0 5.0
1998 153 40.1 39  8.2 192 22.6 4.9
1999 192 49.5 35  7.6 227 26.6 6.5
2000 207 50.7 65 12.9 272 30.2 3.9
2001 199 48.6 57 11.5 256 28.6 4.2
2002 204 50.3 65 13.3 269 30.3 3.8
2003 224 54.7 71 15.0 295 33.2 3.6
2004 213 51.5 74 15.6 287 31.7 3.3
2005 234 55.0 77 16.1 311 33.8 3.4
2006 206 47.9 70 13.8 276 29.2 3.5
2007 232 54.6 61 11.9 293 31.3 4.6
2008 217 48.7 70 13.6 287 29.4 3.6
2009 208 46.5 65 13.4 273 28.2 3.5
2010 228 50.0 73 14.0 301 30.3 3.6
2011 250 53.3 77 14.2 327 31.9 3.7
2012 214 44.2 80 15.3 294 28.3 2.9
2013 194 40.4 70 12.3 264 25.0 3.3
2014 189 36.7 76 13.4 265 24.4 2.7
2015 222 43.8 75 13.2 297 27.04 3.3
*ASR – rate per 100 000 age-standardized to World Standard Population.
TAbLE 2. Results of joinpoint regression analysis of lung cancer mortality in Montenegro from 1990-2015
Category Average annual percentage change 95% confidence interval P
Men 0.6 -0.4-1.6  0.300
Women 3.5 2.1-4.9 <0.001
All 1.3 0.4-2.1 <0.001
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FIGURE 1. Joinpoint regression analysis of overall lung cancer mortality in Montenegro from 1990 to 2015. ASR – rate per 100 000 
age-standardized to World Standard Population. Red square – observed; blue line – 1990-2004 annual percent change (APC) = 3.91*; 
green line – 2004-2015 APC = -1.95*. Asterisk indicates APC that is significantly different from zero at alpha = 0.05.
FIGURE 2. Joinpoint regression analysis mortality of lung cancer in Montenegro. Parallel pairwise comparison between sexes from 
1990-2015; ASR – a rate per 100 000 age-standardized to World Standard Population. Red square – men; blue line – 1990-2005 an-
nual percent change (APC) = 2.88*; green line – 2005-2015 APC = -2.79*; purple dot – female; light blue line – 1990-2004 APC = 7.14*; 
brown line – 2004-2015 APC = -0.93. Asterisk indicates APC that is significantly different from zero at alpha = 0.05; Parallelism refused, 
APC difference = 2.8, 95% CI 0.6-6.2, P < 0.001.
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the entire population and in women after 2004, and in 
men after 2005. About the same time, smoking preva-
lence in Montenegro decreased from 43.8% in 2000 to 
32.7% in 2008 and 31% in 2012 (21-23). However, since it 
usually takes two to three decades for changes in smok-
ing behavior to affect lung cancer trends (7), we cannot 
be certain whether these changes can be attributed to 
decrease in the smoking prevalence or some other fac-
tor. At the same time, it is not clear whether the lung can-
cer mortality trend will continue to rise, but the smoking 
prevalence of 36.2% in men and 34.5% in women found 
in 2017 (31) is still high, warranting the introduction of 
new laws on tobacco ban and better enforcement of the 
existing laws.
The estimated AAPC of lung cancer standardized mortal-
ity rate was lower than the rate of 7.7% per year observed 
in China 1991-2013 (32), and higher than the rate in Croa-
tia (33). While the decreasing trend of cancer mortality in 
Montenegro started in the early year of 21st, in the coun-
tries of South-Eastern Europe, age-standardized lung can-
cer mortality rates in men started to decrease already in 
the period 1999-2008: by 1.2% per year in Slovenia, 0.8% 
per year in Croatia, and 2.5% in Malta, but they increased 
in Bulgaria by 2.0% and Serbia by 2.2% (34). In women, the 
rates decreased by 2.1% in Slovenia, 3.1% in Serbia, and 3.8 
in Romania (34). European Union countries saw the peak of 
lung cancer mortality in men in the late 1980s, followed by 
a decline accompanying reduced tobacco consumption. 
In women, on the other hand, the mortality started grow-
ing from 1970 (35).
The variations in lung cancer mortality rates and trends 
between countries and between men and women within 
each country largely reflect differences in smoking preva-
lence (6,36-38). Some European countries have managed 
to substantially reduce smoking prevalence (39). Countries 
ranked high on Tobacco Control Scale 2016, such as Nor-
way and Iceland (40), from 1980 to 2012 successfully re-
duced smoking prevalence by more than 50% in both men 
and women (41). The lack of smoking prevalence data in 
Montenegro prevents monitoring trends and projections 
of smoking prevalence reduction (42).
To facilitate prevention, as the most cost-effective long-
term strategy for cancer control (43), it is important to un-
derstand lung cancer epidemiology and its causative risk 
factors. Determining lung cancer trends is also of crucial 
importance for national planning programs for lung 
cancer control (8,44,45).
A limitation of our study is the quality of death records, 
including data validity and reliability, especially since no 
study so far has analyzed the quality of mortality data in 
Montenegro. Also, different physicians were responsible 
for coding death causes before and after 2009 and two dif-
ferent classification systems, ICD-9 and ICD-10, were used. 
Furthermore, no studies on lung cancer causes have been 
conducted in Montenegro, so no precise conclusion could 
be made on the causes of changes registered by joinpoint 
regression.
In conclusion, this study observed an increase in lung can-
cer mortality rates during the studied period, which war-
rants improvement and full implementation of tobacco 
control as the main strategy for combating tobacco use.
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